Trade Mark Journal No.2021/053 31 December 2021

WO0000001631334 (5)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:3 November 2021
Date of designation in the UK: 3 November 2021
Image for mark 1631334_TIF VICEOLIS

International priority date claimed: 2 July 2021 (European Union Intellectual Property Office (EUIPO)) (018506585)
Class 5
Pharmaceuticals and medical preparations for human use; pharmaceutical preparations within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for pulmonary fibrosis namely ipf; pharmaceutical preparations for diffuse systemic sclerosis (lung manifestations); pharmaceutical preparations for infectious lung diseases; pharmaceutical preparations for covid-19.

Vicore Pharma AB

Representative: POTTER CLARKSON AB, Convendum Regeringsgatan 48, SE-111 56 Stockholm, SWEDEN